Invera Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
1,561
+767
+97% +$784K 1% 30
2026
Q1
$730K Buy
+794
New +$805K 0.47% 61

Other funds holding LLY

Invera Wealth Advisors's LLY Position: Q2 2026 in Review

Invera Wealth Advisors increased its Eli Lilly (LLY) stake by 97% in Q2 2026, buying an estimated $784K and bringing the position to 1,561 shares worth $1.87M. The position accounts for 1% of the portfolio, ranked #30.

Invera Wealth Advisors first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Invera Wealth Advisors held 1,561 shares of Eli Lilly worth $1.87M as of Q2 2026.
  • Invera Wealth Advisors bought 767 Eli Lilly shares in Q2 2026, an estimated $784K.
  • Eli Lilly made up 1% of Invera Wealth Advisors's portfolio in Q2 2026, its #30 holding.
  • Invera Wealth Advisors first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Invera Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.